JP2023528016A5 - - Google Patents
Info
- Publication number
- JP2023528016A5 JP2023528016A5 JP2022573137A JP2022573137A JP2023528016A5 JP 2023528016 A5 JP2023528016 A5 JP 2023528016A5 JP 2022573137 A JP2022573137 A JP 2022573137A JP 2022573137 A JP2022573137 A JP 2022573137A JP 2023528016 A5 JP2023528016 A5 JP 2023528016A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- nucleotides
- acid according
- chain
- strand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382449.5 | 2020-05-27 | ||
| EP20382449 | 2020-05-27 | ||
| EP20382947.8 | 2020-10-30 | ||
| EP20382947 | 2020-10-30 | ||
| PCT/EP2021/064077 WO2021239825A1 (en) | 2020-05-27 | 2021-05-26 | Nucleic acids for inhibiting expression of cnnm4 in a cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528016A JP2023528016A (ja) | 2023-07-03 |
| JP2023528016A5 true JP2023528016A5 (cg-RX-API-DMAC7.html) | 2024-05-31 |
Family
ID=76355448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573137A Pending JP2023528016A (ja) | 2020-05-27 | 2021-05-26 | 細胞におけるｃｎｎｍ４の発現を阻害するための核酸 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240229041A2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4158023A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023528016A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230018429A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021281511A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3184050A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021239825A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024013334A1 (en) * | 2022-07-15 | 2024-01-18 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of agt in a cell |
| JPWO2024172057A1 (cg-RX-API-DMAC7.html) * | 2023-02-15 | 2024-08-22 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9201440A (nl) | 1992-08-11 | 1994-03-01 | Univ Leiden | Triantennaire clusterglycosiden, hun bereiding en toepassing. |
| EP3228326A1 (en) | 2016-04-05 | 2017-10-11 | Silence Therapeutics GmbH | Nucleic acid linked to a trivalent glycoconjugate |
| WO2018185253A1 (en) * | 2017-04-05 | 2018-10-11 | Silence Therapeutics Gmbh | Ligand modified double-stranded nucleic acids |
| WO2020109316A1 (en) * | 2018-11-26 | 2020-06-04 | Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune | Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease |
-
2021
- 2021-05-26 WO PCT/EP2021/064077 patent/WO2021239825A1/en not_active Ceased
- 2021-05-26 CA CA3184050A patent/CA3184050A1/en active Pending
- 2021-05-26 JP JP2022573137A patent/JP2023528016A/ja active Pending
- 2021-05-26 KR KR1020227045417A patent/KR20230018429A/ko active Pending
- 2021-05-26 AU AU2021281511A patent/AU2021281511A1/en active Pending
- 2021-05-26 EP EP21731058.0A patent/EP4158023A1/en active Pending
- 2021-05-26 US US17/999,956 patent/US20240229041A2/en active Pending